What it is
Proton therapy accelerates hydrogen nuclei (protons) and directs them at the tumour. Because protons stop at a set depth, tissue beyond the tumour receives almost no radiation.
Its effect on the cancer is similar to conventional radiation; its strength lies in sparing what surrounds the tumour.
Who it suits
It is used for childhood cancers where a growing body must be protected, tumours next to the eye, brain or spinal cord, head-and-neck cancer, liver cancer, and selected lung and oesophageal cancers. It is also considered when a recurrence has to be re-irradiated.
It is not a standard treatment for cancer that has spread to several organs, or for blood cancers. The remote review answers based on your stage and the tumour's location.
How it proceeds
Simulation and planning take one to two weeks, followed by 10–35 sessions, five days a week. Each session takes about 30 minutes including set-up.
Children may need sedation to stay still, so a paediatric anaesthesia team is on hand. The concierge arranges family accommodation and schedules.
Duration and recovery
Skin changes and fatigue can occur but mostly settle once treatment ends. Most patients can fly home within days of the last session.
Response assessment and follow-up continue remotely once you are home.
Cost
Korean national insurance covers some cancers for residents; international patients pay the hospital's international rate. Because it varies widely by cancer type and number of sessions, the cost is confirmed by quote.
The review fee is credited against your bill when you go ahead with treatment.
In Korea
Korea runs two proton centres, with more due from 2028. Paediatric proton therapy is a long-established field in Korea.
Hospital names and results are not listed here; the opinion compares three hospitals for you.
Frequently asked questions
- Can children be treated?
- Yes. Childhood cancer is one of the main indications. A paediatric anaesthesia team is on hand when sedation is needed, and the concierge helps with family accommodation and schooling.
- Which is better, protons or carbon ions?
- Neither is better in itself — only better suited. Where sparing healthy tissue comes first, protons are considered; where radiation resistance is the issue, carbon ions. The opinion states which applies to you.
- Why is the stay long?
- It comes down to the number of sessions: 10–35 at five a week works out at 4–7 weeks. Accommodation is arranged within walking distance of the hospital.
Clinical trials recruiting in Korea auto-updated · 2026-09-29
Fetched daily from ClinicalTrials.gov. Whether you can take part is answered in the opinion, based on stage.
| NCT | Phase | Sponsor | Updated |
|---|---|---|---|
| A Study of PHN-012 in Patients With Advanced Solid Tumors NCT07127874 | PHASE1 | Pheon Therapeutics | 2026-09-29 |
| Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301) NCT06881784 | PHASE3 | Revolution Medicines, Inc. | 2026-09-29 |
| DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy NCT07472517 | PHASE3 | Boehringer Ingelheim | 2026-09-29 |
| A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003) NCT07227597 | PHASE1/PHASE2 | Merck Sharp & Dohme LLC | 2026-09-29 |
| A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015) NCT07554339 | PHASE3 | Merck Sharp & Dohme LLC | 2026-09-29 |
| A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301] NCT07099898 | PHASE3 | GlaxoSmithKline | 2026-09-28 |
Recent literature auto-updated · 2026-09-29
Review articles from the last five years, fetched daily from PubMed.
- The Impact of Nanoparticles on Proton Therapy: A Review Study. — Cancers, 2026
- Upright Immobilization for Proton Therapy: A Critical Review and Single-Institution Experience. — International journal of radiation oncology, biology, physics, 2026
- Effects of proton therapy on the tumor immune system and clinical implications: A review. — Precision radiation oncology, 2026
- Assessing the Economic Feasibility and Social Impact of Proton Therapy: Implementation in Mexico and Latin America. — International journal of radiation oncology, biology, physics, 2026
- Radiotherapy Strategies for WHO Grade 1 Meningioma: A Systematic Review and Meta-Analysis Comparing Proton Therapy, Conventional Radiotherapy, and Radiosurgery. — Cancers, 2026
- Proton beam therapy: neuroradiology considerations and challenges. — Clinical radiology, 2026
Related cancers
Statistics on this page are official national statistics, not the results of any particular hospital. Outcomes differ by stage and by individual health. Discuss diagnosis and treatment decisions with your physicians.